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A B S T R A C T
The difference of test results between patients with »pure« atopic dermatitis (AD) and
»mixed« AD (with concomitant respiratory allergy, RA) was investigated in 30 AD pa-
tients. The results showed the onset of disease that mostly occur in the early infancy 15
(50%) patients had developed the disease under the age of 2 – 2/10 in »pure« AD, and
13/20 in »mixed« AD. Twenty (66.6%) of them had a history of RA (»mixed« AD) whe-
reas the remaining 10 (33.3%) had »pure« AD. Seventeen (56.6%) AD patients had one
concomitant allergic disease, while 3 (10%) patients had two comorhid conditions (AR
and AB) each. Family history was positive for atopy in 22 (73.3%) AD patients in 14
(46.6%) patients in a first-degree relative. Twenty-four (80%) patients had positive
prick test 9/10 (90%) in »pure« AD and 15/20 (75%) in »mixed« AD, mostly for house
dust (20). Positive scratch test was observed in 16 (53.3%) patients 4/10 in »pure« AD,
and 12/20 in »mixed« AD. Nineteen (63.3%) AD patients showed positive patch test re-
action 5/10 in »pure« AD, and 14/20 in »mixed« AD. AD patients had higher serum
IgE (21/30) than non-atopic ones but similar in »pure« AD, and »mixed« AD 7/10
(70%) in »pure« AD, and 14/20 (70%) in »mixed« AD. Determination of CD23 marker
on B-lymphocytes showed normal values in 24, and increased values in six patients
2/10 in »pure« AD, and 4/20 in »mixed« AD. The values of CD21 were decreased in 16
AD patients 6/10 in »pure« AD, and 10/20 in »mixed« AD. HLA-DR expression was
normal in almost all patients. There were no statistically significant differences (p<0.05)
between the »pure« AD and »mixed« AD patient groups, except for the age at onset, which
was younger in the group of patients with concomitant RA. Accordingly, study results
pointed to the association between AD and RA.
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Introduction
Previous studies have demonstrated
similar mechanisms to be involved in the
pathogenesis of atopic diseases, e.g., al-
lergic bronchial asthma (AB), allergic
rhinoconjunctivitis (AR), and atopic der-
matitis (AD)1–5.
The difficulties with the use of the
term atopic disease rest in the fact that
they are associated with IgE-mediated al-
lergic reactions of the immediate type
(type I of Coombs and Gell), whereas in
AD there is a combined action of several
immunologic and nonimmunologic fac-
tors1. There is an increasing evidence
that the activation of T helper cells pro-
ducing Th2-related cytokines with IL-4,
IL-5 and IL-6 but not IL-2 and inter-
feron-gamma (IFN-gamma) may be in-
volved in their pathogenesis6.
Atopic dermatitis usually manifests in
the early infancy. The concomitant symp-
toms of respiratory allergies (RA) occur in
30%–50% of AD patients and usually de-
velop after the childhood phase of AD1–3.
In general, the severity of AD decreases
after the first year of life, skin lesions are
milder and not infrequently disappear
completely by around the age of 30 (Fig-
ures 1 and 2). The relationship of AD
with other atopic manifestations such as
AB or AR has not yet been definitely dem-
onstrated. Because of the similarity of
these diseases, there is a proposal to dis-
tinguish three main subtypes of AD: »mi-
xed« type with concomitant RA, »extrin-
sic« type of »pure« AD without RA but
with allergen-specific IgE, and »intrinsic«
type without immediate type sensitiza-
tions7.
The sensitization of the immediate
type is demonstrated by an immediate
urticarial reaction to the allergens in skin
tests (prick, scratch and intracutaneous
test), and occasionally positive skin tests
of delayed hypersensitivity (patch test).
Even in the early childhood, skin tests
show that these patients exhibit positive
reactions of the immediate type to food
and inhalant allergens. Skin tests and
determination of increased IgE values
are common diagnostic parameters, how-
ever, recent flow cytometry studies of cell
markers on B-lymphocytes (e.g., CD21
and CD23) and T-lymphocytes (e.g.,
HLA-DR) may contribute to the under-
standing of the pathogenesis of AD.
The aim of our study was to examine
by different test parameters the aller-
gologic status in AD patients and to de-
fine whether AD patients with concomi-
tant RA (»mixed« AD) had more promi-
nent allergologic status and more positive
tests than those without RA (»pure« AD),
thus being at a higher risk of RA.
Subjects and Methods
Subjects
Thirty patients with AD (16 females
and 14 males, aged 4–44 years) and 10
healthy controls (a group of subjects in
whom atopy was definitely excluded; 6 fe-
males and 4 males, aged 5–63 years) par-
ticipated in the clinical study. None of the
subjects had acute infections. AD pa-
tients had typical clinical signs of AD.
The criteria for the diagnosis of AD were
those given by Hanifin & Rajka3. None of
the patients had received any treatment
for at least one week before the study and
none had taken oral steroids.
Study protocol
Data on the skin and respiratory dis-
eases were obtained from personal and
family histories. The subjects were asked
to complete a questionnaire on allergic
respiratory disorders, and were clinically
examined. Consultations were performed
by a dermatologist, and history data on
allergic disorders were reviewed and dis-
cussed with each subject. Information
was obtained on the past and/or current
symptoms of AD, allergic rhinoconjun-
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ctivitis (AR), allergic bronchitis/asthma
(AB), and family history of allergic dis-
eases. The severity of AD was determined
according to the criteria defined elsewhe-
re8.
The aim was to define whether AD pa-
tients with concomitant RA (»mixed« AD)
had more prominent allergologic status
and more positive tests than those with-
out RA (»pure« AD), thus being at a grea-
ter risk for the development of RA.
Methods
Skin prick tests to a standard series of
inhalant and nutritive allergens and
scratch test to preservatives and addi-
tives were performed using commercial
solutions (supplied by the Institute of Im-
munology, Zagreb). Negative (50% mix of
glycerin and saline) reaction and positive
(histamine) controls were included. The
tests were performed on clinically unin-
volved skin on the subjects’ forearms. The
wheal diameter was measured at 20 min-
utes, and a diameter of > 3 mm was taken
as positive9. The result was considered
positive if at least one allergen of the
standard test series was positive.
The epicutaneous (patch) test was car-
ried out with the standard series aller-
gens according to the International Con-
tact Dermatitis Research Group (ICDRG)
in adult patients with AD and in children
aged > 59–11. Patch test results with one
or more plus (+) to particular contact al-
lergens were considered positive accord-
ing to ICDRG.
The values of total IgE were deter-
mined by the standardized radioimmu-
nosorbent test (Pharmacia, Uppsala,
Sweden) and enzyme-linked immunosor-
bent assay (ELISA)9,11. The upper limit
normal for IgE values was 150 IU/mL in
adults, and was age-adjusted in chil-
dren11,12. The expression of CD21 and
CD23 markers on B-lymphocytes and of
HLA-DR on T-lymphocytes was determi-
ned in peripheral blood (three-color
immunofluorescence analysis on a flow
cytometer - immunophenotyping)13. Ref-
erence values were the following: CD23
(0–8%), CD21 (12.6 3.8%), and HLA-DR
(10–32%).
Statistics
The results were statistically analy-
zed. Tables of frequency, mean values and
standard deviations were determined for
all parameters studied. The  2-test and
Mann-Whitney’s test were used to evalu-
ate group differences (p<0.05). Statisti-
cally significant differences between the
two groups according to different para-
meters are marked with an asterisk (*).
Centile distribution of each parameter in
patients with »pure« AD and »mixed« AD
and HC was also analyzed.
Results
The results obtained showed an al-
most equal sex distribution of AD pa-
tients (16 female and 14 male) (Table 1).
Concerning the age at onset, the early in-
fancy was found to prevail; 15 (50%) pa-
tients developed the disease under the
age of 2, and six patients between 2 and
5, while nine patients had a later onset of
the disease. The age at onset was younger
in patients with »mixed« AD than in
those with »pure« AD. The difference was
statistically significant. Twenty (66.6%)
AD patients had a history of RA (»mixed«
AD), whereas the remaining ten (33.3%)
had no history of RA (»pure« AD). Seven-
teen (56.6%) patients had coexistence of
one allergic disease, while three (10%)
patients had two coexistent conditions
(AR and AB). Family history was positive
for atopy in 22 (73.3%) AD patients, in 14
(46.6%) of them in a first-degree relative.
Respiratory allergies were found in
20/30 (66.6%) AD patients allergic rhini-
tis/conjunctivitis in 12/30 (40%), allergic
bronchitis/asthma in 11/30 (36.6%), and a
combination of both in 3/30 (10%) (Table
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1). However, out of 30 AD patients, 10
(33.3%) had »pure« AD, and 20 (66.6%)
suffered from a »mixed« type with con-
comitant RA (Table 1).
Table 1 shows that most of AD pa-
tients – 22/30 (73.3%) had positive family
history of allergic diseases and positive
first-degree relatives in 14 (46.6%) cases.
Patients with »pure« AD had a lower rate
(6/10) of respiratory allergic diseases in
family history than those with »mixed«
AD (16/20) (Table 1).
The severity of diseases is illustrated
in Table 2, and parental history in Tables
2 and 3. Patients with »mixed« AD had a
higher rate of positive parental history
(9/20) than those with »pure« AD (2/10)
(Table 2). The results showed that there
was no patient whose both parents had
RA (Table 3).
According to prick test results, the
rate of positive reactions was not greater
in patients with »mixed« AD than in tho-
se with »pure« AD (Table 4). Patients
with AD had positive prick test results in
24 out of 30 cases (80%) (Table 4). Nine
(90%) of ten patients with »pure« AD and
15 (75%) out of 20 patients with »mixed«
AD had positive prick test (Table 4). The
most common positive reactions were to
house dust, followed by grass pollen and
feather (Table 5). Quite unexpectedly,
338
L. Lugovi} and J. Lipozen~i}: Respiratory Allergic Diseases, Coll. Antropol. 24 (2000) 2: 335–345
TABLE 1










Male: Female 14:16 6:4 8:12 4:6
Mean age 18:6 18:8 18:5 18:7
*Age at onset (yrs)
< 2 15 2 13 0
2–5 6 3 3 0
> 5 9 5 4 0
Associated RA 20 0 20 0
One disease 17 0 0 0
Allergic
rhinitis/conjunctivitis (AR) 12 0 12 0
Allergic
bronchitis/asthma (AB) 11 0 11 0
Other 0 0 0 0
 2 diseases 3 0 3 0
None 10 10 0 0
Family history
Positive 22 6 16 0
1st degree 14 2 12 0
2nd degree 8 4 4 0
Negative 8 4 4 0
*Statistically significant difference
food allergens were found to predominate
over aeroallergens in prick tests as could
not be expected (aeroallergens in 6/10 in
»pure« AD, and 13/20 in »mixed« AD; food
allergens in 8/10 in »pure« AD, and 14/20
in »mixed« AD). Positive reactions to pre-
servatives and additives were observed in
16 patients (4/10 in »pure« AD and 12/20
in »mixed« AD) (Table 4). The highest
rate of positive reaction was recorded for
acetylsalicylic acid (Table 6). Nineteen
out of 30 AD patients showed positive
patch test reactions with the standard se-
ries of contact allergens. The most com-
mon positive reactions were those to ni-
ckel (12 patients), bichromate (10) and
charcoal tar (9) (Table 7). All healthy con-
trols had negative personal and family
history of the disease, and negative skin
tests.
The values of IgE were mostly increa-
sed (Table 8). Patients with »pure« AD
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TABLE 2
SEVERITY OF AD ON CLINICAL EXAMINATION AND PARENTAL HISTORY IN 30 AD PATIENTS
AD severity /
Parental history
Total (N=30) »Pure« AD (n=10) »Mixed« AD (n=20)
14 male 16 female 6 male 4 female 8 male 2 female
Mild 3 3 1 2 2 1
Moderate 9 12 4 2 5 10
Severe 2 1 1 0 1 1
Negative 19 8 11
Positive 11 2 9
maternal history 9 1 2
paternal history 2 1 1
TABLE 3
ATOPIC DISEASES IN PARENTAL HISTORY OF 30 AD PATIENTS
Parental history Parental history
+ Negative Positive Single Double
AD 25 5 5 0
AR 24 6 6 0
Asthma 29 1 1 0
Total (N=30) 19 11 11 0
TABLE 4
CUTANEOUS TEST RESULTS IN AD PATIENTS

























Negative 6 1 5 14 6 8 11 5 6
Positive 24 9 15 16 4 12 19 5 14
showed increased values of IgE in 7/10
(70%) cases, similarly to those with »mi-
xed« AD 14/20 (70%). The prevalence of
IgE increase was not greater in patients
with »mixed« AD compared to those with
»pure« AD. In both patient groups, serum
IgE level mostly exceeded the normal
limits, however, the difference between
groups did not reach statistical signifi-
cance. Accordingly, patients with »mixed«
AD generally had higher IgE values6.
Determination of CD23 marker on
B-lymphocytes showed normal values in
24, and increased values in six patients
(2/10 in »pure« AD, and 4/20 in »mixed«
AD). The values of CD21 were decreased
in 16 AD patients (6/10 in »pure« AD, and
10/20 in »mixed« AD). Normal values of
HLA-DR were recorded in almost all pa-
tients (29 patients had normal values and
one patient had a decreased value). All
healthy controls had normal values of
CD23, CD21 and HLA-DR.
The results obtained yielded no statis-
tically significant difference between the
two groups according to any of the pa-
rameters examined, except for the age at
onset of the disease (Tables 1, 8). Centile
distribution of skin test results and num-
ber of allergens showed similar values in
the two groups, with no significant differ-
ence between them. The same was ob-
served for CD21 and CD23 markers on
B-lymphocytes, and for HLA-DR on
T-lymphocytes. So, the values of the ma-
jority of parameters differed, however,
with no regular changes in their distribu-
tion. It is important to note that the sam-
ple was small, so the results cannot be
considered representative. However, the
results showed a statistically significant
difference only for the age at onset, while
other parameters would obviously requi-
re a greater study sample for reveal the
possible regularity of changes.
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TABLE 5
MOST COMMON POSITIVE PRICK TEST










House dust 20 7 13
Grass pollen 14 5 9
Phleum pratense 2 1 1
Dactylis glomerata 1 1 0
Poa pratensis 1 1 0
Feather 10 4 6
Straw 9 4 5
Flour 8 1 7
wheat flour 5 3 2
barley flour 2 1 1
maize flour 1 1 0
Coffee 8 3 5
Mite (Dermatophagoides
pteronyssinus) 7 3 4
Bean 7 3 5
Pea 7 2 2
Hemp 6 4 2
Cocoa 6 2 4
Animal hair 6 0 6
Tree pollen 5 2 3
Milk 5 1 4
Sea herb 4 0 4
Soya beans 4 1 3
Parsley 3 0 3
TABLE 6
NUMBER OF AD PATIENTS WITH POSITIVE











Acetylsalicylic acid 12 1 11
Potassium
metabisulfate 10 3 7
Sodium benzoate 7 2 5
Tartrazine 7 4 3
Although the assessment of most pa-
rameters (skin tests, IgE, and CD21,
CD23 and HLA-DR markers) yielded no
statistically significant difference be-
tween the two groups, some conclusions
could be drawn. Thus, the minimal IgE
values were considerably lower in pa-
tients with »pure« AD than in those with
»mixed« AD. Furthermore, the majority
of centile values of other parameters were
higher in patients with »pure« AD than in
those with »mixed« AD. The values of
HLA-DR were higher in »pure« AD pa-
tients than in »mixed« AD patients and
healthy controls. The values in centile
distribution showed an upward shift in
patients with »pure« AD compared with
patients with »mixed« AD. No statisti-
cally significant difference was observed
in the analysis of CD21, CD23 and
HLA-DR values, although in some centile
distribution patterns they were higher in
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TABLE 7
MOST COMMON ALLERGENS IN POSITIVE EPICUTANEOUS TEST RESULTS IN 30 AD PATIENTS
Allergen






Nickel sulfate 12 3 9
Potassium bichromate 10 3 7
Charcoal tar 9 2 7
Cobalt chloride 8 2 6
Fragrance mix 7 1 6
Balsam of Peru 4 0 4
Carba - compounds 4 2 2
Black rubber mix 2 0 2
Anaesthesyn 2 0 2
»Rubel« detergent 1 0 1
Colophony 1 0 1
»Vim« detergent 1 0 1
TABLE 8






IgE Normal (–150) 9 3 6
151–300 4 2 2
> 300 17 5 12
CD21 Decreased 16 6 10
Normal (–150) 13 4 9
Increased 1 0 1
CD23 Normal 24 8 16
Increased 6 2 4
HLA-DR Decreased 1 0 1
Normal 29 10 19
»mixed« AD patients than in »pure« AD
patients.
However, there was no statistically
significant difference (p<0.05) between
the »pure« AD and »mixed« AD patient
groups, except for the age at onset, which
was younger in the group of patients with
concomitant RA.
Discussion
According to the literature, nearly a
half of AD patients show clinical signs of
concomitant respiratory allergies (»mi-
xed« AD)1–3. Thus, Hanifin and Rajka
found manifestations of RA in roughly
50% of AD patients3. Similarly, Diepgen
and Fartasch found »mixed« AD in 46% of
patients with AD12. Wüthrich found that
about 60% of patients with AD had asso-
ciated RA7. We found respiratory aller-
gies in 20/30 (66.6%) AD patients and
»pure« AD in 10/30 (33.3%) of the pa-
tients, which is consistent with literature
data. Sampson reported on concomitant
atopic diseases in 80% of AD patients: al-
lergic rhinitis in 25%, asthma in 10%,
both asthma and allergic rhinitis in 45%,
and neither of the two in 20%14.
Of course, the figures vary with the
age of the population: e.g., many infants
with AD may not develop respiratory
symptoms until much later3. One fourth
to one third of AD children will have re-
spiratory symptoms as well as skin mani-
festations of AD15. It is the patient with
both respiratory and skin symptoms who
tends to have more severe diseases, both
respiratory and cutaneous, and a poorer
prognosis for both15. Our study showed a
statistically significant difference in the
age at onset between the »pure« AD and
»mixed« AD group, with an earlier onset
in the »mixed« AD group. Patients with
concomitant RA had a younger age at on-
set than those with »pure« AD. It may in-
dicate that an early onset of AD often
brings concomitant RA, and that infants
with very early signs of AD are candi-
dates for the manifestation of RA16,17. So,
when working with small children with
AD, physicians should borne in mind that
there is a high probability that they
would develop RA later in life. Hochreu-
tener showed clinically relevant respira-
tory allergy in 15% of AD children (rhi-
noconjunctivitis in 10%, inspiratory
stridor in 2.5% and bronchial asthma in
15% of AD children)18. Larsen et al. often
found asthma in personal history of boys
(6.1%), and in family history of girls
(11.7%)19. Hanifin and Rajka found one or
more manifestations of atopy in family
history in approximately 70% of AD pa-
tients3.
In allergic asthma and allergic rhini-
tis, the causative allergens can often be
found, but allergens causing or worsen-
ing skin conditions can seldom be de-
tected in AD7. There are different at-
tempts to determine allergic reactions of
type I: by means of skin tests (early hy-
persensitivity tests), specific IgE deter-
mination by RAST or ELISA, specific
provocation tests, etc.20 The results vary
and the percentage of positive skin test
reactions ranges from 50% to over 90%1–7.
Some authors report that AD patients
with AB or AR (»mixed« AD) show signifi-
cantly more frequent positive test reac-
tions to inhalant allergens, particularly
house dust, house dust mites, pollen, and
animal allergens (animal hairs and
scales) than other subjects1. Even if no
concrete concepts exist about the causal
significance of inhalant allergens in the
precipitation or exacerbation of AD, it is
possible that seasonal phases of AR can
be related to a deterioration of the skin
disesase, and vice versa. The pathogenic
role of other environmental inhalant al-
lergens is rather difficult to demonstrate,
because of the widespread and perennial
occurrence of house dust mites and
moulds, and frequent polyvalent IgE sen-
sitization. In our study, skin tests to the
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standard series of inhalant allergens
identified aeroallergens as the most com-
mon allergens causing skin allergy. It is
interesting that some AD patients exhib-
ited no evidence of positive allergic reac-
tions to some allergens, although they
had AD. We also observed some patients
with »mixed« AD who showed no evidence
of positive prick test to at least one aller-
gen, although they clinically had AD with
concomitant RA, characteristic of a
strong atopic status.
Atopic dermatitis, asthma and AR are
commonly classified as atopic diseases,
because the increased levels of IgE in the
serum have been proposed as a common
etiologic factor20,21. The IgE response is so
far a facultative attribute of AD and ac-
cording to Hanifin and Rajka only a mi-
nor diagnostic criterion. Patients with
»pure« AD in 20%–40% do not have in-
creased total IgE and specific IgE7. How-
ever, one should borne in mind that in
20%–40% of »pure« AD cases neither ele-
vated IgE levels nor specific IgE sensiti-
zation can be found7. Serum IgE level is
raised in a majority of patients with se-
vere AD1. Some authors found the IgE
levels to be more often increased in AD
patients with concurrent respiratory
tract manifestations (allergic asthma, al-
lergic rhinitis)7. Van Voorst Vader et al.
found elevated median serum IgE in pa-
tients with »mixed« AD compared with
the median serum IgE in »pure« AD22. We
found increased levels of IgE in seven out
of 10 (70%) patients with »pure« AD, and
in 14 out of 20 (70%) patients with »mi-
xed« AD, and no difference between the
two groups indicating no changes of the
allergologic status in »mixed« AD. How-
ever, as the serum IgE level may be with-
in the normal limits even in some paients
with extensive skin lesions, the determi-
nation of IgE level is of no pathognomonic
significance. In some AD patients, exac-
erbation of asthma may cause that the
skin lesions seem to disappear, and vice
versa2. In Ring’s investigation, only 10%
of patients with AD exhibited an alter-
nating pattern of the diseases2. Some pa-
tients, however, clearly showed a coinci-
dental exacerbation of both skin lesions
and respiratory symptoms during aller-
gen exposure2. However, the association
of AD and RA may be evident23–26.
Delayed hypersensitivity type IV (cell-
mediated immunity) is considered to be
involved in the pathogenesis of AD27–33.
Therefore, determination of the cells and
their markers (e.g., CD23) could be of im-
portance for the disease. In some recent
studies it has been indicated that a low-
affinity IgE receptor, FcRII (CD23), has
an important role in the pathogenesis of
AD. The expression of CD23 receptors on
the peripheral blood mononuclear cells
(PBMC) was analyzed in AD patients34–36.
Some authors showed an increased CD23
positive lymphocyte count in allergic pa-
tients as compared with controls13. Taki-
gawa et al. examined the effect of per-
sonal RA on the frequency of expression
of CD23 receptor, and concluded that the
presence of personal respiratory allergy
per se did not influence the frequency of
CD23+ PBMC8. Allergic patients were
found to have elevated CD23 as well as
CD21 when compared with controls13,35.
There also was a positive correlation be-
tween CD23 and total serum IgE levels in
allergic children13,35. These results stress
the role of the CD21-CD23 ligand-pair in-
teraction in IgE-mediated diseases13,35,36.
Determination of HLA-DR markers on
peripheral blood T-lymphocytes, perfor-
med in our study, showed normal values
in almost all AD patients, although acti-
vated (HLA- DR+) T-lymphocytes predo-
minated in the dermal infiltrate.
It is commonly considered that RA is
often the reason for inducing skin lesions
in AD, but our study showed no difference
in the allergologic parameters and status
between AD patients with and without
concomitant RA. Future studies may ho-
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pefully provide more data on the patho-
genesis of this fascinating disease, and
entail some important implications for
the treatment of the different manifesta-
tions of the atopy syndrome.
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JESU LI RESPIRACIJSKE ALERGIJSKE BOLESTI POVEZANE
S ATOPIJSKIM DERMATITISOM?
S A @ E T A K
Razlika u rezultatima testova izme|u bolesnika s »~istim« atopijskim dermatitisom
(AD) i »mije{anim« AD-om (s prate}om respiracijskom alergijom, RA) istra`ivala se u
30 bolesnika s AD-om. Rezultati su pokazali da se bolest ve}inom javlja u ranoj dje~joj
dobi u 15 (50%) bolesnika do 2. godine - 2/10 u »~istom« AD-u, a 13/20 u »mije{anom«
AD-u. Dvadeset (66,6%) bolesnika je imalo RA u anamnezi (»mije{ani« AD), dok je
ostalih 10 (33,3%) imalo »~isti« AD. Sedamnaestero (56,6%) bolesnika s AD-om imalo je
jo{ jednu alergijsku bolest, dok je troje (10%) imalo po dvije alergijske bolesti (AR i AB).
Atopija u obiteljskoj anamnezi je zamije}ena u 22 (73,3%) bolesnika s AD-om 14
(46,6%) bolesnika u bli`em srodstvu. Dvadeset~etvoro (80%) bolesnika je imalo po-
zitivan ubodni test 9/10 (90%) u »~istom« AD-u, a 15/20 (75%) u »mije{anom« AD-u,
naj~e{}e na ku}nu pra{inu (20). Pozitivan skarifikacijski test je zabilje`en u 16 (53,3%)
bolesnika 4/10 u »~istom« AD-u, a 12/20 u »mije{anom« AD-u. Devetnaestoro (63,3%)
bolesnika s AD-om je imalo pozitivan patch test 5/10 u »~istom« AD-u, a 14/20 u »mi-
je{anom« AD-u. Bolesnici s AD-om su imali vi{e vrijednosti serumskog IgE-a (21/30)
od neatopi~ara, ali sli~ne u »~istom« i »mije{anom« AD-u 7/10 (70%) u »~istom« AD-u, a
14/20 (70%) u »mije{anom« AD-u. Odre|ivanja biljega CD23 na B-limfocitima su poka-
zala normalne vrijednosti u 24, a povi{ene u {estoro bolesnika (2/10 u »~istom« AD-u, a
4/20 u »mije{anom« AD-u). Vrijednosti CD21 ve}inom su bile sni`ene - u 16 bolesnika s
AD-om (6/10 u »~istom« AD-u, a 10/20 u »mije{anom« AD-u). Ekspresija HLA-DR je
bila u granicama normale u gotovo svih bolesnika. Nije uo~ena statisti~ki zna~ajna
razlika (p<0,05) izme|u skupina bolesnika s »~istim« AD-om i »mije{anim« AD-om,
osim u dobi po~etka bolesti koja je bila ni`a u bolesnika s prate}om respiracijskom
alergijom. Dakle, postoji povezanost izme|u AD-a i RA.
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